MITSUBISHI TANABE PHARMA PATENTS FACING OPPOSITIONS
Top patents of MITSUBISHI TANABE PHARMA facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP2896397B2 | 07 Oct, 2020 | Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter | NA | 2 | |
| EP2252289B1 | 23 Oct, 2019 | Combination Therapy Comprising Sglt Inhibitors And Dpp4 Inhibitors | NA | 1 | |
| EP2754440B1 | 03 Apr, 2019 | Medicinal Agent For Treating Amyotrophic Lateral Sclerosis Or Preventing Progression Of Phase Of Amyotrophic Lateral Sclerosis | Sep, 2032 | 1 | |
| EP1714960B1 | 28 Mar, 2018 | Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als | Feb, 2025 | 1 |